These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33530582)

  • 1. Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells.
    Zabulica M; Jakobsson T; Ravaioli F; Vosough M; Gramignoli R; Ellis E; Rooyackers O; Strom SC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling.
    Akbari S; Sevinç GG; Ersoy N; Basak O; Kaplan K; Sevinç K; Ozel E; Sengun B; Enustun E; Ozcimen B; Bagriyanik A; Arslan N; Önder TT; Erdal E
    Stem Cell Reports; 2019 Oct; 13(4):627-641. PubMed ID: 31522975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.
    Asai A; Aihara E; Watson C; Mourya R; Mizuochi T; Shivakumar P; Phelan K; Mayhew C; Helmrath M; Takebe T; Wells J; Bezerra JA
    Development; 2017 Mar; 144(6):1056-1064. PubMed ID: 28275009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.
    Hendriks D; Artegiani B; Hu H; Chuva de Sousa Lopes S; Clevers H
    Nat Protoc; 2021 Jan; 16(1):182-217. PubMed ID: 33247284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors.
    Ishikawa T; Kobayashi M; Yanagi S; Kato C; Takashima R; Kobayashi E; Hagiwara K; Ochiya T
    PLoS One; 2015; 10(4):e0123193. PubMed ID: 25875613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes.
    Werder RB; Kaserman JE; Packer MS; Lindstrom-Vautrin J; Villacorta-Martin C; Young LE; Aratyn-Schaus Y; Gregoire F; Wilson AA
    Mol Ther; 2021 Nov; 29(11):3219-3229. PubMed ID: 34217893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
    Hirshorn ST; Steele N; Zavros Y
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency.
    Sin YY; Price PR; Ballantyne LL; Funk CD
    Sci Rep; 2017 May; 7(1):2585. PubMed ID: 28566761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of hepatobiliary organoids from human induced pluripotent stem cells.
    Wu F; Wu D; Ren Y; Huang Y; Feng B; Zhao N; Zhang T; Chen X; Chen S; Xu A
    J Hepatol; 2019 Jun; 70(6):1145-1158. PubMed ID: 30630011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
    Wang L; Ye Z; Jang YY
    Exp Biol Med (Maywood); 2021 Apr; 246(7):861-875. PubMed ID: 33467883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and Future Perspectives of Using Human-Induced Pluripotent Stem Cells and Organoid Against Liver Failure.
    Kuse Y; Taniguchi H
    Cell Transplant; 2019 Dec; 28(1_suppl):160S-165S. PubMed ID: 31838891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic engineering in organoids.
    Teriyapirom I; Batista-Rocha AS; Koo BK
    J Mol Med (Berl); 2021 Apr; 99(4):555-568. PubMed ID: 33459801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrogation of the Atherosclerosis-Associated
    Wang X; Raghavan A; Peters DT; Pashos EE; Rader DJ; Musunuru K
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):76-82. PubMed ID: 29097363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic or Induced Pluripotent Stem Cell-Derived Hepatocellular Systems for HCV Culture.
    Wu X; Dao Thi VL
    Methods Mol Biol; 2019; 1911():121-135. PubMed ID: 30593622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creating rat hepatocyte organoid as an
    He YT; Zhu XL; Li SF; Zhang BQ; Li Y; Wu Q; Zhang YL; Zhou YY; Li L; Qi YN; Bao J; Bu H
    World J Stem Cells; 2020 Oct; 12(10):1184-1195. PubMed ID: 33178400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.